BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 20594772)

  • 1. Live Brucella abortus rough vaccine strain RB51 stimulates enhanced innate immune response in vitro compared to rough vaccine strain RB51SOD and virulent smooth strain 2308 in murine bone marrow-derived dendritic cells.
    Surendran N; Hiltbold EM; Heid B; Sriranganathan N; Boyle SM; Zimmerman KL; Makris MR; Witonsky SG
    Vet Microbiol; 2011 Jan; 147(1-2):75-82. PubMed ID: 20594772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat-killed and γ-irradiated Brucella strain RB51 stimulates enhanced dendritic cell activation, but not function compared with the virulent smooth strain 2308.
    Surendran N; Hiltbold EM; Heid B; Sriranganathan N; Boyle SM; Zimmerman KL; Witonsky SG
    FEMS Immunol Med Microbiol; 2010 Nov; 60(2):147-55. PubMed ID: 20812951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of recombinant B. abortus strain RB51SOD toward understanding the uncorrelated innate and adaptive immune responses induced by RB51SOD compared to its parent vaccine strain RB51.
    Zhu J; Larson CB; Ramaker MA; Quandt K; Wendte JM; Ku KP; Chen F; Jourdian GW; Vemulapalli R; Schurig GG; He Y
    Front Cell Infect Microbiol; 2011; 1():10. PubMed ID: 22919576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ability of Brucella abortus rough vaccine strains to elicit DC and innate immunity in lung using a murine respiratory model.
    Surendran N; Zimmerman K; Seleem MN; Sriranganathan N; Boyle SM; Hiltbold EM; Lawler H; Heid B; Witonsky SG
    Vaccine; 2010 Oct; 28(43):7009-15. PubMed ID: 20727395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51.
    Vemulapalli R; He Y; Cravero S; Sriranganathan N; Boyle SM; Schurig GG
    Infect Immun; 2000 Jun; 68(6):3286-9. PubMed ID: 10816475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of vaccination strategies against intranasal challenge with Brucella abortus in BALB/c mice.
    Surendran N; Sriranganathan N; Lawler H; Boyle SM; Hiltbold EM; Heid B; Zimmerman K; Witonsky SG
    Vaccine; 2011 Mar; 29(15):2749-55. PubMed ID: 21316499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase-2-dependent dendritic cell death, maturation, and priming of T cells in response to Brucella abortus infection.
    Li X; He Y
    PLoS One; 2012; 7(8):e43512. PubMed ID: 22927979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of antigen-specific Th1-type immune responses by gamma-irradiated recombinant Brucella abortus RB51.
    Sanakkayala N; Sokolovska A; Gulani J; Hogenesch H; Sriranganathan N; Boyle SM; Schurig GG; Vemulapalli R
    Clin Diagn Lab Immunol; 2005 Dec; 12(12):1429-36. PubMed ID: 16339067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of TLRs in Brucella mediated murine DC activation in vitro and clearance of pulmonary infection in vivo.
    Surendran N; Hiltbold EM; Heid B; Akira S; Standiford TJ; Sriranganathan N; Boyle SM; Zimmerman KL; Makris MR; Witonsky SG
    Vaccine; 2012 Feb; 30(8):1502-12. PubMed ID: 22234268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection to respiratory challenge of Brucella abortus strain 2308 in the lung.
    Surendran N; Sriranganathan N; Boyle SM; Hiltbold EM; Tenpenny N; Walker M; Zimmerman K; Werre S; Witonsky SG
    Vaccine; 2013 Aug; 31(38):4103-10. PubMed ID: 23845817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brucella abortus RB51: enhancing vaccine efficacy and developing multivalent vaccines.
    Vemulapalli R; He Y; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2002 Dec; 90(1-4):521-32. PubMed ID: 12414168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Booster vaccination with safe, modified, live-attenuated mutants of Brucella abortus strain RB51 vaccine confers protective immunity against virulent strains of B. abortus and Brucella canis in BALB/c mice.
    Truong QL; Cho Y; Kim K; Park BK; Hahn TW
    Microbiology (Reading); 2015 Nov; 161(11):2137-48. PubMed ID: 26341622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
    Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
    Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brucella abortus vaccine strain RB51 produces low levels of M-like O-antigen.
    Cloeckaert A; Zygmunt MS; Guilloteau LA
    Vaccine; 2002 Mar; 20(13-14):1820-2. PubMed ID: 11906770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of Brucella suis and Brucella abortus rough strains with human dendritic cells.
    Billard E; Dornand J; Gross A
    Infect Immun; 2007 Dec; 75(12):5916-23. PubMed ID: 17938225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of formyltransferase (wbkC) gene generates a Brucella abortus rough strain that is attenuated in macrophages and in mice.
    Lacerda TL; Cardoso PG; Augusto de Almeida L; Camargo IL; Afonso DA; Trant CC; Macedo GC; Campos E; Cravero SL; Salcedo SP; Gorvel JP; Oliveira SC
    Vaccine; 2010 Aug; 28(34):5627-34. PubMed ID: 20580469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspase-2 mediated apoptotic and necrotic murine macrophage cell death induced by rough Brucella abortus.
    Chen F; He Y
    PLoS One; 2009 Aug; 4(8):e6830. PubMed ID: 19714247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses.
    Vemulapalli R; He Y; Boyle SM; Sriranganathan N; Schurig GG
    Infect Immun; 2000 Jun; 68(6):3290-6. PubMed ID: 10816476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.